Semenza (16) have shown that treatment of tumorbearing mice with digoxin to reduce HIF-1α expression significantly diminished primary tumor growth and lymph node metastasis, implying that induction of a HIF inhibitor to the therapeutic regimen of the selected group of breast cancer patients can be beneficial. The gene discussed is HIF1A; the disease is breast cancer.